A. Omma Et Al. , "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial," HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18, 2022
Omma, A. Et Al. 2022. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial. HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18 .
Omma, A., Batirel, A., Aydin, M., Karadag, F. Y., Erden, A., KÜÇÜKŞAHİN, O., ... Armagan, B.(2022). Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial. HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18.
Omma, Ahmet Et Al. "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial," HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18, 2022
Omma, Ahmet Et Al. "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial." HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18, 2022
Omma, A. Et Al. (2022) . "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial." HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.18.
@article{article, author={Ahmet Omma Et Al. }, title={Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial}, journal={HUMAN VACCINES & IMMUNOTHERAPEUTICS}, year=2022}